Pharma Mirror

JUNE 23, 2023

LAUSANNE, Switzerland – Viseven, a leading global MarTech services provider for the Pharma and Life Sciences industries, is thrilled to announce its partnership with SpotMe, an enterprise event platform tailored to high-touch industries. This collaboration marks a significant milestone in digital communication within the healthcare industry.

Life Science 130

Life Science 130

Bio Pharma Dive

NOVEMBER 10, 2021

The company, which had its treatment rejected by the FDA in August, eliminated 30 jobs and 70 open positions. An upcoming meeting with the agency looms as a key event.

Drugs 171

Drugs 171

BioSpace

DECEMBER 6, 2023

In an R&D event on Thursday, the French pharma is trying to win over its investors by highlighting a dozen potential blockbusters and charting strong growth for the company through 2030.

103

103

Pharmaceutical Technology

JUNE 8, 2023

While the company previously shared interim biomarker and safety data from the Phase I/II AEROW trial (NCT05248230) in November 2022, the update features further results detailing the drug’s effects on quality-of-life and spirometry-measured outcomes in a limited set of patients. 4DMT presented the results on 8 June at 5pm CET.

Gene Therapy 246

Gene Therapy Gene Development Trials 246

XTalks

APRIL 16, 2024

This year’s summit promises to be an essential event for anyone involved in food safety and quality assurance. Here are four compelling reasons to attend the event, each supported by detailed insights that underscore the summit’s value to professionals in the field.

Regulation 105

Regulation Compliance Allergies Manufacturing 105

Drug Channels

APRIL 8, 2024

This unique, new event will be held from March 17 to 19, 2025, at the Turnberry Resort and Spa in Miami. And of course, I'll be there to moderate the entire event and lead the fireside chats. Thanks to DCI’s partnership with HMP Global, we can bring this novel event to the drug channels community. Hope you can join us!

Drugs 73

Drugs Pharmacy Manufacturing 73

Pharmaceutical Technology

FEBRUARY 10, 2023

4D Molecular Therapeutics (4DMT), the California-based biotechnology company focused on developing gene therapies for rare and large market diseases, has had the FDA place a clinical hold onto its Fabry disease (FD) gene therapy program (4D-310).

Gene Therapy 264

Gene Therapy Gene Trials Marketing 264

Fierce Pharma

JULY 21, 2023

A week after ADC Therapeutics paused its Zynlonta trial to review seven deaths and five other respiratory events in patients who received the drug, the company has scrapped the study altogether fol | After severe respiratory events and seven deaths held up ADC's Zynlonta study in unfit or frail patients with previously untreated diffuse large (..)

Trials 81

Trials Drugs 81

Pharma Mirror

APRIL 6, 2022

CPHI North America will be held as a SMART event, with three weeks of dedicated pharma learning and partnering. The benefit for the CPHI pharma community, which relies on a widening global supply chain, is that a SMART event format stimulates greater collaboration within the industry. Adam Andersen, Executive Vice.

Research 130

Research 130

Pharmaceutical Technology

APRIL 20, 2023

The regulatory clearance allows the company to commence its planned Phase IIa placebo-controlled, randomised, crossover, double-blind, multi-centre, multiple-dose trial of ZT-01 to assess its effect on the frequency of nocturnal hypoglycaemia events in Type 1 diabetes mellitus.

Insulin 130

Insulin Trials Drugs 130

Pharma Marketing Network

OCTOBER 31, 2023

Event marketing is a form of marketing that involves face-to-face interactions between a brand or product and potential customers. In the digital age, event marketing is becoming increasingly important for companies in the pharmaceutical industry. What is Event Marketing?

Marketing 52

Marketing Branding Production Pharma Companies 52

Intouch Solutions

NOVEMBER 16, 2023

Last week, Frontiers Health, the premier global digital health innovation event, was held in Rome, Italy. The annual event assembled nearly 1,000 attendees from over 40+ countries across the healthcare ecosystem to learn, network and explore industry challenges, strategic trends and solutions in life sciences and healthcare.

Life Science 105

Life Science Medicine Pharma Companies Branding 105

Pharmaceutical Technology

MAY 12, 2023

Speciality pharmaceutical company SERB Pharmaceuticals has acquired exclusive US rights for bentracimab from SFJ Pharmaceuticals. In partnership with SERB Pharmaceuticals, the company will also file a biologics licence application (BLA) to the US Food and Drug Administration (FDA) later this year.

FDA Approval 130

FDA Approval Clinical Trials Clinical Trials Antibody 130

Pharma Mirror

APRIL 24, 2022

The event – which unites major players in pharmaceutical packaging, drug delivery, medical devices and machinery – returns to the Paris Expo, Porte de Versailles (Hall 7.2) Pharmapack Europe will be held as Smart Event to enhance the benefits for global attendees, providing a hybrid experience that extends the.

Drug Delivery 130

Drug Delivery Packaging Packaging Drugs 130

BioPharma Reporter

MAY 22, 2023

US biopharma Insmed has announced progress across its early-stage research programs at the company's investor and analyst event, The Future of Rare at Insmed: Functional Genes, AI-Enhanced Proteins, Glowing Algae, and More.

Research 89

Research Protein Gene Development 89

Intouch Solutions

NOVEMBER 9, 2023

The contributions raised by this event fund lifesaving research, advocacy and support for blood cancer patients and their families. During the lantern walk, EVERSANA INTOUCHers collectively reflected on their experience and the importance companies like EVERSANA play to continue supporting patients and these organizations.

Research 105

Research 105

pharmaphorum

NOVEMBER 25, 2021

Healthcare professional (HCP) engagement experienced significant shifts during the acute phase of the pandemic, as COVID-19 forced a rethink of traditional pharmaceutical sales and marketing practices, including the digitisation of events. The changing events model. Before COVID, pharma events were mainly face-to-face.

Pharma Companies 98

Pharma Companies Production Sales Marketing 98

Outsourcing Pharma

AUGUST 30, 2023

With more than 63 biopharma companies attending and 15 event partners sharing solutions, the 7th Annual IPF Summit being held in Boston next month (September 2023) is not to be missed.

72

72

STAT News

MARCH 28, 2023

In recent years, companies have introduced a dizzying array of ambitious new naloxone products. They include a mechanized injector that gives robotic voice commands , a prefilled syringe pen, an ultra-high-dose nasal spray, and an autoinjector that the Pentagon has purchased for use in the event of a terrorist attack. As the U.S.

Drugs 135

Drugs Production 135

Pharma Mirror

NOVEMBER 18, 2021

The China specific findings of the CPhI Annual Report rankings[1] are released ahead of CPhI & P-MEC China – which will take place in hybrid form, with Virtual Expo Connect running digitally from November 18th until December 18th, and the in-person event held at the Shanghai New International Expo Center (SNIEC) December 16-18th, 2021.

130

130

Outsourcing Pharma

AUGUST 28, 2023

With more than 63 biopharma companies attending and 15 event partners sharing solutions, the 7th annual IPF Summit being held in Boston next month (September 2023) is not to be missed.

72

72

Pharmaceutical Technology

APRIL 19, 2023

While the Clarksville, US-based company completed a Phase Ia study in healthy participants to eventually develop the drug for Alzheimer’s disease, it is likely that the company will now focus on Parkinson’s disease in its Phase II study first, said Kelleher-Andersson.

Trials 130

Trials Drugs Licensing Licensing 130

Fierce Pharma

JUNE 29, 2023

By 2030, Sanofi figures its immunizations could generate more than €10 billion in annual sales, the company said during a vaccines R&D event Thursday. While Dupixent often steals the show, Sanofi isn’t sleeping on its vaccine franchise. |

Sales 88

Sales Vaccination Vaccine 88

Pharmaceutical Technology

FEBRUARY 2, 2023

Having made significant advances in a relatively short period of time, CRISPR research is now edging closer to reaching the clinic , and this month’s cover story takes a look at the major players in this field and the big events that could break through this year.

Gene Therapy 246

Gene Therapy Gene Pharma Companies Clinical Trials 246

Pharmaceutical Technology

FEBRUARY 28, 2023

Rhythm Pharmaceuticals’ subsidiary Rhythm Pharmaceuticals Netherlands has purchased Dutch biotech company Xinvento and its portfolio of investigational therapeutics. The post Rhythm buys Dutch biotech company Xinvento appeared first on Pharmaceutical Technology.

Genetic Disease 130

Genetic Disease Genetics Sales Development 130

Fierce Pharma

AUGUST 3, 2023

As Novo Nordisk and Eli Lilly rack up significant sales from their GLP-1 diabetes and obesity drugs, the companies also must gear up for defense against lawsuits from new users. |

Medicine 95

Medicine Sales Drugs 95

Pharmaceutical Technology

JUNE 1, 2023

According to the company’s website, the Phase IIb is planned to begin in early 2024. Andrews, UK-based company raised the funds from the venture investment company Esperante Ventures, alongside existing investors Thairm Bio and Scottish Enterprise. The company dosed the first patient for this study in August 2022.

In-Vitro 130

In-Vitro Engineer Protein Vaccination 130

STAT News

FEBRUARY 17, 2023

The companies disclosed Friday that violations of Good Clinical Practice, the international ethical and quality standards used by all clinical researchers, had been found at sites run by an undisclosed trial operator, leading Pfizer and Valneva to drop trial participants at those locations. Continue to STAT+ to read the full story…

Trials 119

Trials Drug Trials Clinical Trials Clinical Trials 119

BioSpace

JUNE 13, 2023

The cell therapy company said Seattle Children’s, its partner, paused the Phase I trial for acute myeloid leukemia after a recent Grade 5 (fatal) serious adverse event. The cause is under investigation.

Trials 76

Trials 76

Pharmaceutical Technology

JULY 27, 2022

Headache, fall, back pain, procedural pain and pain in extremities were the most frequent adverse events (AEs) reported in subjects who received tofersen in VALOR and the OLE study. of subjects who received tofersen in VALOR and OLE studies had serious neurologic events including myelitis, aseptic meningitis, radiculitis and papilledema.

Trials 246

Trials Clinical Trials Clinical Trials Genetics 246

Pharmaceutical Technology

MAY 12, 2023

While the company is expected to present this data through a live stream, the abstract is already live. In December 2022, the company presented data from the first two patients treated in the Phase I/II RUBY (NCT04853576) trial. Neither subject reported vaso-occlusive events at time of last data point cut-off.

Gene Therapy 246

Gene Therapy Gene Development Drugs 246

Pharma Mirror

JUNE 6, 2021

The company will be present at the digital flagship event of the global process industries during the whole of June and will be live during 15-16th June. The company will be deploying a compelling portfolio of solutions in the field of pharmaceutical manufacturing.

Engineer 130

Engineer Manufacturing Production Development 130

Pharma Mirror

JANUARY 30, 2023

The event – which is at the heart of pharma’s packaging and drug delivery devices industry – returns to the Paris Expo, Porte de Versailles (Hall 7.2)

Packaging 130

Packaging Packaging Drug Delivery Drugs 130

STAT News

NOVEMBER 30, 2022

Elon Musk’s brain-machine interface company Neuralink aims to put its first implant in a human subject in the next six months, he said during an event Wednesday.

Drugs 119

Drugs 119

Outsourcing Pharma

APRIL 12, 2022

A recent online event hosted by the patient services company invited a number of women to share their experience and insights working in the research field.

Clinical Research 90

Clinical Research Research Clinical Development Development 90

pharmaphorum

JULY 20, 2021

COVID-19 had a huge, and very obvious, initial impact on medical congresses and symposia when 2020’s lockdowns took effect, with many events struggling to move quickly enough to a purely digital format. Different time zones: the geographical spread of attendees presented challenges for optimising availability beyond the live event.

Pharma Companies 105

Pharma Companies Research 105

BioPharma Reporter

NOVEMBER 10, 2020

Sinovacâs Phase 3 COVID-19 vaccine trial has been put on hold in Brazil after a serious adverse event. But in a statement this morning, the company says the event is not related to the vaccine.

Vaccination 92

Vaccination Vaccine Trials Development 92